全文获取类型
收费全文 | 11439篇 |
免费 | 622篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 177篇 |
儿科学 | 525篇 |
妇产科学 | 152篇 |
基础医学 | 1234篇 |
口腔科学 | 253篇 |
临床医学 | 790篇 |
内科学 | 2786篇 |
皮肤病学 | 206篇 |
神经病学 | 707篇 |
特种医学 | 428篇 |
外国民族医学 | 1篇 |
外科学 | 1775篇 |
综合类 | 265篇 |
一般理论 | 8篇 |
预防医学 | 504篇 |
眼科学 | 504篇 |
药学 | 989篇 |
中国医学 | 30篇 |
肿瘤学 | 767篇 |
出版年
2023年 | 75篇 |
2022年 | 141篇 |
2021年 | 349篇 |
2020年 | 223篇 |
2019年 | 240篇 |
2018年 | 324篇 |
2017年 | 254篇 |
2016年 | 308篇 |
2015年 | 349篇 |
2014年 | 484篇 |
2013年 | 566篇 |
2012年 | 961篇 |
2011年 | 972篇 |
2010年 | 554篇 |
2009年 | 469篇 |
2008年 | 752篇 |
2007年 | 823篇 |
2006年 | 751篇 |
2005年 | 638篇 |
2004年 | 594篇 |
2003年 | 539篇 |
2002年 | 448篇 |
2001年 | 113篇 |
2000年 | 134篇 |
1999年 | 139篇 |
1998年 | 81篇 |
1997年 | 52篇 |
1996年 | 42篇 |
1995年 | 45篇 |
1994年 | 47篇 |
1993年 | 25篇 |
1992年 | 48篇 |
1991年 | 58篇 |
1990年 | 44篇 |
1989年 | 42篇 |
1988年 | 33篇 |
1987年 | 24篇 |
1986年 | 34篇 |
1985年 | 27篇 |
1984年 | 31篇 |
1983年 | 21篇 |
1982年 | 13篇 |
1981年 | 20篇 |
1979年 | 25篇 |
1975年 | 15篇 |
1974年 | 23篇 |
1973年 | 17篇 |
1972年 | 28篇 |
1970年 | 15篇 |
1967年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
2.
3.
Harit Kapoor Kush Raj Lohani Tommy H. Lee Devendra K. Agrawal Sumeet K. Mittal 《CTS Clinical and Translational Science》2015,8(6):841-847
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long‐standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5‐year survival <20%. The disease is known to sequentially progress from reflux esophagitis to a metaplastic precursor, Barrett''s esophagus and then onto dysplasia and esophageal adenocarcinoma. However, only few patients with reflux develop Barrett''s esophagus and only a minority of these turn malignant. The reason for this heterogeneity in clinical progression is unknown. To improve patient management, molecular changes which facilitate disease progression must be identified. Animal models can provide a comprehensive functional and anatomic platform for such a study. Rats and mice have been the most widely studied but disease homology with humans has been questioned. No animal model naturally simulates the inflammation to adenocarcinoma progression as in humans, with all models requiring surgical bypass or destruction of existing antireflux mechanisms. Valuable properties of individual models could be utilized to holistically evaluate disease progression. In this review paper, we critically examined the current animal models of Barrett''s esophagus, their differences and homologies with human disease and how they have shaped our current understanding of Barrett''s carcinogenesis. 相似文献
4.
5.
6.
Viviana Maestrini Lucia I. Birtolo Sara Cimino Paolo Severino Massimo Mancone Marco Francone Sanjay M. Banypersad Flavia Ventriglia Luigi Tritapepe Fabio Miraldi Francesco Fedele 《Echocardiography (Mount Kisco, N.Y.)》2019,36(5):992-995
A 20‐year‐old Congolese woman presented with presyncope, dyspnea, and anasarca. Past medical history was unremarkable. Echocardiography revealed a rare combination of giant right atrium (RA), a dilated and hypertrophied right ventricle, subvalvular pulmonary stenosis (subPS), severe tricuspid regurgitation (TR), pericardial effusion and what appeared to be a spontaneously closed ventricular septal defect (VSD). Cardiac Magnetic Resonance and Cardiac Computed Tomography confirmed the findings excluding the presence of intra‐cardiac and extra‐cardiac shunt and other associated congenital anomalies. The patient underwent subPS resection, right atrioplasty, and tricuspid annuloplasty. Multimodality approach facilitated the detection of the abnormalities and provided clarity when determining the optimal surgical strategy. 相似文献
7.
8.
9.
Peritonitis is a common emergency encountered by surgeons the world over. This paper aims to provide an overview of the spectrum
of peritonitis seen in the East. Studies dealing with the overall spectrum of secondary peritonitis in various countries of
this region were identified using Pubmed and Google. These were analyzed for the site and cause of perforation and the mortality.
It was observed that perforation of duodenal ulcers was the most the commonly encountered perforations. These are followed
by small bowel and appendicular perforations. Colonic perforations were uncommon. The overall mortality ranges between 6–27%. 相似文献
10.
Ashutosh Singh M.Ch. Vidyut Kumar Sinha M.Ch. Jayant Khandekar M.Ch. Nandkishor Agrawal M.Ch. Anil Patwardhan M.Ch. Dr. Jagdish Kharideparkar M.Ch. 《Indian Journal of Thoracic and Cardiovascular Surgery》2006,22(2):121-125
Objective The degree of Left Ventricular Mass Index (LVMI) regression following aortic valve replacement correlates with long-term survival.
This study aims to assess the extent of LVMI regression at 3 months following aortic valve replacement (AVR) with different
types and sizes of mechanical valves in rheumatic aortic valve disease.
Methods The LVMI regression was studied in 34 consecutive patients, undergoing elective AVR for rheumatic aortic stenosis and/or regurgitation.
They were grouped in A and B, matched in age, body surface area and pre-operative LVMI, receiving respectively a tilting disc
and a bileaflet mechanical valve. The LVMI was calculated by M-mode echocardiography using the Devereux' formula pre-operatively
and three months post-operatively. The trend of LVMI reduction was compared between the two groups and amongst the patients
with stenotic, regurgitant and mixed aortic valve, pathologies; and receiving different sizes of valves.
Results The mean preoperative LVMI was 199g±79.5 g/m2. At three months post aortic valve replacement, the mean LVMI was 130g±49.0 g/m2. There was a significant reduction of LVMI post-operatively (p=0.001) at three months follow-up. The extent of LVMI regression
following surgery amongst the groups A and B did not vary significantly (p=0.92). The extent of LVMI regression did not vary
significantly in patients with different aortic valve pathology nor with different sizes of the valves implanted.
Conclusions There is a significant early LVMI regression following aortic valve replacement in rheumatic aortic valve disease. The type
and the size of the mechanical prosthesis or the rheumatic pathology do not appear to influence this regression. 相似文献